Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 2,882Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 9Harvoni

PharmaCompass

01

Brand Name : Harvoni

Ledipasvir

arrow
Antibody Engineering
Not Confirmed

Brand Name : Harvoni

arrow
Antibody Engineering
Not Confirmed

Ledipasvir

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2020 Revenue in Millions : 272

2019 Revenue in Millions : 643

Growth (%) : -58

blank

02

Brand Name : Harvoni

Ledipasvir

arrow
Antibody Engineering
Not Confirmed

Brand Name : Harvoni

arrow
Antibody Engineering
Not Confirmed

Ledipasvir

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2021 Revenue in Millions : 212

2020 Revenue in Millions : 272

Growth (%) : -22

blank

03

Brand Name : Harvoni

Ledipasvir

arrow
Antibody Engineering
Not Confirmed

Brand Name : Harvoni

arrow
Antibody Engineering
Not Confirmed

Ledipasvir

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2022 Revenue in Millions : 114

2021 Revenue in Millions : 212

Growth (%) : -46

blank

04

Brand Name : Harvoni

Ledipasvir

arrow
Antibody Engineering
Not Confirmed

Brand Name : Harvoni

arrow
Antibody Engineering
Not Confirmed

Ledipasvir

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2023 Revenue in Millions : 70

2022 Revenue in Millions : 115

Growth (%) : -39

blank

05

Brand Name : Harvoni

Ledipasvir and Sofosbuvir

arrow
Antibody Engineering
Not Confirmed

Brand Name : Harvoni

arrow
Antibody Engineering
Not Confirmed

Ledipasvir and Sofosbuvir

Main Therapeutic Indication : Infectious Diseases (HIV, Hepatitis...

Currency : USD

2015 Revenue in Millions : 2,127

2014 Revenue in Millions : 13,864

Growth (%) : 552%

blank

06

Brand Name : Harvoni

Ledipasvir And Sofosbuvir

arrow
Antibody Engineering
Not Confirmed

Brand Name : Harvoni

arrow
Antibody Engineering
Not Confirmed

Ledipasvir And Sofosbuvir

Main Therapeutic Indication : Infectious Diseases (HIV, Hepatitis...

Currency : USD

2016 Revenue in Millions : 9,081

2015 Revenue in Millions : 13,864

Growth (%) : -34

blank

07

Brand Name : Harvoni

Ledipasvir and Sofosbuvir

arrow
Antibody Engineering
Not Confirmed

Brand Name : Harvoni

arrow
Antibody Engineering
Not Confirmed

Ledipasvir and Sofosbuvir

Main Therapeutic Indication : Infectious Diseases (HIV, Hepatitis...

Currency : USD

2017 Revenue in Millions : 4,370

2016 Revenue in Millions : 9,081

Growth (%) : -52

blank

08

Brand Name : Harvoni

Ledipasvir And Sofosbuvir

arrow
Antibody Engineering
Not Confirmed

Brand Name : Harvoni

arrow
Antibody Engineering
Not Confirmed

Ledipasvir And Sofosbuvir

Main Therapeutic Indication : Infectious Diseases (HIV, Hepatitis...

Currency : USD

2018 Revenue in Millions : 1,222

2017 Revenue in Millions : 4,370

Growth (%) : -72%

blank

09

Brand Name : Harvoni

Ledipasvir

arrow
Antibody Engineering
Not Confirmed

Brand Name : Harvoni

arrow
Antibody Engineering
Not Confirmed

Ledipasvir

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2019 Revenue in Millions : 643

2018 Revenue in Millions : 1,222

Growth (%) : -47

blank